 | Monter d'un niveau |
Orlando, L., Maiello, E., Orditura, M., Diana, A., Antoniol, G., Morritti, M. G., Aieta, M., Ciccarese, M., Pisconti, S., Bordonaro, R., Russo, A., Febbraro, A., Schiavone, P., Quaranta, A., Caliolo, C., Loparco, D., Cinefra, M., Colucci, G., & Cinieri, S. (2024). Phase II randomized trial comparing metronomic anthracycline-containing chemotherapy versus standard schedule in untreated HER2 negative advanced breast cancer: activity and quality of life results of the GOIM 21003 trial. The Breast, 75, 103725 (7 pages). Disponible
